Biological and Pharmacological Activity of Chitosan and Derivatives

Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics

Volumn , Issue , 2012, Pages 75-92

  Cunha, Teresa ^a   Teixeira, Branca ^a   Santos, Bárbara ^a   Almeida, Marlene ^a   Dias, Gustavo ^a   Das Neves, José ^b  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antidiabetic activity; Antioxidant properties of chitosan; Cationic polysaccharide from chitin, by partial deacetylation; Chitosan and derivatives, pharmacological properties; Chitosan in therapy and alternative medicine; Chitosan, and its derivatives stimulating cytokine production; Chitosan, antibacterial and antifungal activity; Chitosan, biological and pharmacological activity; Chitosan, tools in development of drug delivery carriers

Indexed keywords

EID: 84885497728     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119962977.ch5     Document Type: Chapter

References (172)

1. Illum, L. (1998) Chitosan and its use as a pharmaceutical excipient. Pharm. Res., 15, 1326-1331.
2. Rinaudo, M. (2006) Chitin and chitosan: properties and applications. Prog. Polym. Sci., 31, 603-632.
3. Kato,Y., Onishi, H. and Machida,Y. (2003) Application of chitin and chitosan derivatives in the pharmaceutical field. Curr. Pharm. Biotechnol., 4, 303-309.
4. Kumar, M.N., Muzzarelli, R.A., Muzzarelli, C. et al. (2004) Chitosan chemistry and pharmaceutical perspectives. Chem. Rev., 104, 6017-6084.
5. Rabea, E.I., Badawy, M.E., Stevens, C.V. et al. (2003) Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules, 4, 1457-1465.
6. Goy, R.C., de Britto, D. and Assis, O.B.G. (2009) A review of the antimicrobial activity of chitosan. Polímeros, 19, 241-247.
7. Raafat, D. and Sahl, H.-G. (2009) Chitosan and its antimicrobial potential-a critical literature survey. Microb. Biotech., 2, 186-201.
8. Alburquenque, C., Bucarey, S.A., Neira-Carrillo, A. et al. (2010) Antifungal activity of low molecular weight chitosan against clinical isolates of Candida spp. Med. Mycol., 48, 1018-1023.
9. Tajdini, F., Amini, M.A., Nafissi-Varchehand, N. and Faramarzi, M.A. (2010) Production, physiochemical and antimicrobial properties of fungal chitosan from Rhizomucor miehei and Mucor racemosus. Int. J. Biol. Macromol., 47, 180-183.
10. Fernandes, J.C., Tavaria, F.K., Soares, J.C. et al. (2008) Antimicrobial effects of chitosans and chitooligosaccharides, upon Staphylococcus aureus and Escherichia coli, in food model systems. Food Microbiol., 25, 922-928.
11. Gonil, P., Sajomsang, W., Ruktanonchai, U.R. et al. (2011) Novel quaternized chitosan containing b-cyclodextrin moiety: synthesis, characterization and antimicrobial activity. Carbohydr. Polym., 83, 905-913.
12. Andres,Y., Giraud, L., Gerente, C. and Le Cloirec, P. (2007) Antibacterial effects of chitosan powder: mechanisms of action. Environ. Technol., 28, 1357-1363.
13. Park, Y., Kim, M.H., Park, S.C. et al. (2008) Investigation of the antifungal activity and mechanism of action of LMWS-chitosan. J. Microbiol. Biotech., 18, 1729-1734.
14. Didenko, L.V., Gerasimenko, D.V., Konstantinova, N.D. et al. (2005) Ultrastructural study of chitosan effects on Klebsiella and staphylococci. Bull. Exp. Biol. Med., 140, 356-360.
15. Raafat, D., von Bargen, K., Haas, A. and Sahl, H.G. (2008) Insights into the mode of action of chitosan as an antibacterial compound. Appl. Environ. Microbiol., 74, 3764-3773.
16. Eweis, M., Elkholy, S.S. and Elsabee, M.Z. (2006) Antifungal efficacy of chitosan and its thiourea derivatives upon the growth of some sugar-beet pathogens. Int. J. Biol. Macromol., 38, 1-8.
17. Liu, X.F., Guan, Y.L., Yang, D.Z. et al. (2001) Antibacterial action of chitosan and carboxymethylated chitosan. J. Appl. Polym. Sci., 79, 1324-1335.
18. Muzzarelli, R.A. (2010) Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers. Mar. Drugs, 8, 292-312.
19. Porporatto, C., Bianco, I.D., Riera, C.M. and Correa, S.G. (2003) Chitosan induces different L-arginine metabolic pathways in resting and inflammatory macrophages. Biochem. Biophys. Res. Commun., 304, 266-272.
20. Feng, J., Zhao, L. and Yu, Q. (2004) Receptor-mediated stimulatory effect of oligochitosan in macrophages. Biochem. Biophys. Res. Commun., 317, 414-420.
21. Lee, D.Y., Choi, I.S., Han, J.H. and Yoo, H.S. (2002) Chitosan and D-glucosamine induce expression of Th1 cytokine genes in porcine spleen cells. J. Vet. Med. Sci., 64, 645-648.
22. Nishimura, K., Nishimura, S., Nishi, N. et al. (1984) Immunological activity of chitin and its derivatives. Vaccine, 2, 93-99.
23. Nishimura, K., Nishimura, S., Nishi, N. et al. (1985) Adjuvant activity of chitin derivatives in mice and guinea-pigs. Vaccine, 3, 379-384.
24. Nishimura, K., Ishihara, C., Ukei, S. et al. (1986) Stimulation of cytokine production in mice using deacetylated chitin. Vaccine, 4, 151-156.
25. Chen, C.L., Wang, Y.M., Liu, C.F. and Wang, J.Y. (2008) The effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation. Biomaterials, 29, 2173-2182.
26. Yang, E.-J., Kim, J.-G., Kim, J.-Y. et al. (2010) Anti-inflammatory effect of chitosan oligosaccharides in RAW264.7 cells. Centr. Eur. J. Biol., 5, 95-102.
27. Yoon, H.J., Moon, M.E., Park, H.S. et al. (2007) Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells. Biochem. Biophys. Res. Commun., 358, 954-959.
28. Fernandes, J.C., Spindola, H., de Sousa, V. et al. (2010) Anti-inflammatory activity of chitooligosaccharides in vivo. Mar. Drugs, 8, 1763-1768.
29. Zaharoff, D.A., Rogers, C.J., Hance, K.W. et al. (2007) Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine, 25, 2085-2094.
30. Porporatto, C., Canali, M.M., Bianco, I.D. and Correa, S.G. (2009) The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen. Clin. Exp. Immunol., 155, 79-87.
31. Xie, W., Xu, P. and Liu, Q. (2001) Antioxidant activity of water-soluble chitosan derivatives. Bioorg. Med. Chem. Lett., 11, 1699-1701.
32. Xing, R., Liu, S., Guo, Z. et al. (2005) Relevance of molecular weight of chitosan and its derivatives and their antioxidant activities in vitro. Bioorg. Med. Chem., 13, 1573-1577.
33. Yang, Y., Shu, R., Shao, J. et al. (2006) Radical scavenging activity of chitooligosaccharide with different molecular weights. Eur. Food Res. Tech., 222, 36-40.
34. Fernandes, J.C., Eaton, P., Nascimento, H. et al. (2010) Antioxidant activity of chitooligosaccharides upon two biological systems: erythrocytes and bacteriophages. Carbohydr. Polym., 79, 1101-1106.
35. Tomida, H., Fujii, T., Furutani, N. et al. (2009) Antioxidant properties of some different molecular weight chitosans. Carbohydr. Res., 344, 1690-1696.
36. Liu, H.T., Li,W.M., Xu, G. et al. (2009) Chitosan oligosaccharides attenuate hydrogen peroxide-induced stress injury in human umbilical vein endothelial cells. Pharmacol. Res., 59, 167-175.
37. Xu, Q., Ma, P., Yu, W. et al. (2010) Chitooligosaccharides protect human embryonic hepatocytes against oxidative stress induced by hydrogen peroxide. Mar. Biotechnol., 12, 292-298.
38. Anraku, M., Fujii, T., Furutani, N. et al. (2009) Antioxidant effects of a dietary supplement: reduction of indices of oxidative stress in normal subjects by water-soluble chitosan. Food Chem. Toxicol., 47, 104-109.
39. Anraku, M., Fujii, T.,Kondo,Y. et al. (2011) Antioxidant properties of high molecular weight dietary chitosan in vitro and in vivo. Carbohydr. Polym., 83, 501-505.
40. Dass, C.R. and Choong, P.F. (2008) The use of chitosan formulations in cancer therapy. J. Microencapsul., 25, 275-279.
41. Suzuki, K., Mikami, T., Okawa, Y. et al. (1986) Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose. Carbohydr. Res., 151, 403-408.
42. Jeon, Y.-J. and Kim, S.-K. (2002) Antitumor activity of chitosan oligosaccharides produced in ultrafiltration membrane reactor system. J. Microbiol. Biotech., 12, 503-507.
43. Qin, C., Du, Y., Xiao, L. et al. (2002) Enzymic preparation of water-soluble chitosan and their antitumor activity. Int. J. Biol. Macromol., 31, 111-117.
44. Maeda, Y. and Kimura, Y. (2004) Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J. Nutr., 134, 945-950.
45. Nam, K.S. and Shon, Y.H. (2009) Suppression of metastasis of human breast cancer cells by chitosan oligosaccharides. J. Microbiol. Biotech., 19, 629-633.
46. Guminska, M., Ignacak, J. andWojcik, E. (1996) In vitro inhibitory effect of chitosan and its degradation products on energy metabolism in Ehrlich ascites tumour cells (EAT). Pol. J. Pharmacol., 48, 495-501.
47. Kong, C.S., Bahn, Y.E., Kim, B.K. et al. (2010) Antiproliferative effect of chitosan-added kimchi in HT-29 human colon carcinoma cells. J. Med. Food, 13, 6-12.
48. Yakovlev, G.I., Mitkevich, V.A., Struminskaya, N.K. et al. (2007) Low molecular weight chitosan is an efficient inhibitor of ribonucleases. Biochem. Biophys. Res. Commun., 357, 584-588.
49. Lin, S.Y., Chan, H.Y., Shen, F.H. et al. (2007) Chitosan prevents the development ofAOM-induced aberrant crypt foci in mice and suppressed the proliferation of AGS cells by inhibiting DNA synthesis. J. Cell. Biochem, 100, 1573-1580.
50. Lee, J.K., Lim, H.S. and Kim, J.H. (2002) Cytotoxic activity of aminoderivatized cationic chitosan derivatives. Bioorg. Med. Chem. Lett., 12, 2949-2951.
51. Huang, R., Mendis, E., Rajapakse, N. and Kim, S.K. (2006) Strong electronic charge as an important factor for anticancer activity of chitooligosaccharides (COS). Life Sci., 78, 2399-2408.
52. Zheng, Y., Yi, Y., Qi, Y. et al. (2006) Preparation of chitosan-copper complexes and their antitumor activity. Bioorg. Med. Chem. Lett., 16, 4127-4129.
53. Qi, L., Xu, Z., Jiang, X. et al. (2005) Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Bioorg. Med. Chem. Lett., 15, 1397-1399.
54. Qi, L. and Xu, Z. (2006) In vivo antitumor activity of chitosan nanoparticles. Bioorg. Med. Chem. Lett., 16, 4243-4245.
55. Qi, L.F., Xu, Z.R., Li, Y. et al. (2005) In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. World J. Gastroenterol., 11, 5136-5141.
56. Xu, Y., Wen, Z. and Xu, Z. (2009) Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an antiangiogenic mechanism. Anticancer Res., 29, 5103-5109.
57. Okamoto, Y., Yano, R., Miyatake, K. et al. (2003) Effects of chitin and chitosan on blood coagulation. Carbohydr. Polym., 53, 337-342.
58. Whang, H.S., Kirsch,W., Zhu,Y.H. et al. (2005) Hemostatic agents derived from chitin and chitosan. Polym. Rev., 45, 309-323.
59. Benesch, J. and Tengvall, P. (2002) Blood protein adsorption onto chitosan. Biomaterials, 23, 2561-2568.
60. Sagnella, S. and Mai-Ngam, K. (2005) Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials. Colloids Surf. B Biointerfaces, 42, 147-155.
61. Klokkevold, P.R., Lew, D.S., Ellis, D.G. and Bertolami, C.N. (1991) Effect of chitosan on lingual hemostasis in rabbits. J. Oral Maxillofac. Surg., 49, 858-863.
62. Klokkevold, P.R., Subar, P., Fukayama, H. and Bertolami, C.N. (1992) Effect of chitosan on lingual hemostasis in rabbits with platelet dysfunction induced by epoprostenol. J. Oral Maxillofac. Surg., 50, 41-45.
63. Yang, J., Tian, F.,Wang, Z. et al. (2008) Effect of chitosan molecular weight and deacetylation degree on hemostasis. J. Biomed. Mater. Res. Part B Appl. Biomater., 84, 131-137.
64. Zhang, J., Xia, W., Liu, P. et al. (2010) Chitosan modification and pharmaceutical/biomedical applications. Mar. Drugs, 8, 1962-1987.
65. Lin, C.W. and Lin, J.C. (2003) Characterization and blood coagulation evaluation of the water-soluble chitooligosaccharides prepared by a facile fractionation method. Biomacromolecules, 4, 1691-1697.
66. Janvikul, W., Uppanan, P., Thavornyutikarn, B. et al. (2006) In vitro comparative hemostatic studies of chitin, chitosan, and their derivatives. J. Appl. Polym. Sci., 102, 445-451.
67. Marchand, C., Rivard, G.E., Sun, J. and Hoemann, C.D. (2009) Solidification mechanisms of chitosan-glycerol phosphate/blood implant for articular cartilage repair. Osteoarthritis Cartilage, 17, 953-960.
68. Vongchan, P., Sajomsang,W., Subyen, D. and Kongtawelert, P. (2002) Anticoagulant activity of a sulfated chitosan. Carbohydr. Res., 337, 1239-1242.
69. Vikhoreva, G., Bannikova, G., Stolbushkina, P. et al. (2005) Preparation and anticoagulant activity of a lowmolecular- weight sulfated chitosan. Carbohydr. Polym., 62, 327-332.
70. Huang, R., Du, Y., Yang, J. and Fan, L. (2003) Influence of functional groups on the in vitro anticoagulant activity of chitosan sulfate. Carbohydr. Res., 338, 483-489.
71. Hirano, S. and Noishiki, Y. (1985) The blood compatibility of chitosan and N-acylchitosans. J. Biomed. Mater. Res., 19, 413-417.
72. Qiu, Y., Zhang, N., Kang, Q. et al. (2009) Fabrication of permeable tubular constructs from chemically modified chitosan with enhanced antithrombogenic property. J. Biomed. Mater. Res. Part B Appl. Biomater., 90, 668-678.
73. Miura, T., Usami, M., Tsuura, Y. et al. (1995) Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice. Biol. Pharm. Bull., 18, 1623-1625.
74. Kondo, Y., Nakatani, A., Hayashi, K. and Ito, M. (2000) Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice. Biol. Pharm. Bull., 23, 1458-1464.
75. Hayashi, K. and Ito, M. (2002) Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice. Biol. Pharm. Bull., 25, 188-192.
76. Liu, S.H., Chang, Y.H. and Chiang, M.T. (2010) Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats. J. Agric. Food Chem., 58, 5795-5800.
77. Yao, H.T., Huang, S.Y. and Chiang, M.T. (2008) A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats. Food Chem. Toxicol., 46, 1525-1534.
78. Lee, H.W., Park, Y.S., Choi, J.W. et al. (2003) Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced noninsulin-dependent diabetes mellitus in rats. Biol. Pharm. Bull., 26, 1100-1103.
79. Pangestuti, R. and Kim, S.K. (2010) Neuroprotective properties of chitosan and its derivatives. Mar. Drugs, 8, 2117-2128.
80. Lee, S.H., Park, J.S., Kim, S.K. et al. (2009) Chitooligosaccharides suppress the level of protein expression and acetylcholinesterase activity induced by Abeta25-35 in PC12 cells. Bioorg. Med. Chem. Lett., 19, 860-862.
81. Je, J.Y. and Kim, S.K. (2005) Water-soluble chitosan derivatives as a BACE1 inhibitor. Bioorg. Med. Chem., 13, 6551-6555.
82. Koo, H.N., Jeong, H.J., Hong, S.H. et al. (2002) High molecular weight water-soluble chitosan protects against apoptosis induced by serum starvation in human astrocytes. J. Nutr. Biochem., 13, 245-249.
83. Zhou, S., Yang, Y., Gu, X. and Ding, F. (2008) Chitooligosaccharides protect cultured hippocampal neurons against glutamate-induced neurotoxicity. Neurosci. Lett., 444, 270-274.
84. Xu, Y., Yu, S., Yang, Y. and Ding, F. (2011) The protective effects of chitooligosaccharides against glucose deprivation-induced cell apoptosis in cultured cortical neurons through activation of PI3K/Akt and MEK/ERK1/2 pathways. Brain Res., 1375, 49-58.
85. Cheng, M., Cao, W., Gao, Y. et al. (2003) Studies on nerve cell affinity of biodegradable modified chitosan films. J. Biomater. Sci. Polym. Ed., 14, 1155-1167.
86. He, Q., Zhang, T., Yang, Y. and Ding, F. (2009) In vitro biocompatibility of chitosan-based materials to primary culture of hippocampal neurons. J. Mater. Sci. Mater. Med., 20, 1457-1466.
87. Yang, Y., Liu, M., Gu, Y. et al. (2009) Effect of chitooligosaccharide on neuronal differentiation of PC-12 cells. Cell Biol. Int., 33, 352-356.
88. Martin-Lopez, E., Nieto-Diaz, M. and Nieto-Sampedro, M. (2010) Differential adhesiveness and neuritepromoting activity for neural cells of chitosan, gelatin, and poly-L-lysine films. J. Biomater. Appl. doi: 10.1177/ 0885328210379928
89. Wang, G., Ao, Q., Gong, K. et al. (2010) The effect of topology of chitosan biomaterials on the differentiation and proliferation of neural stem cells. Acta Biomater., 6, 3630-3639.
90. Leipzig, N.D. and Shoichet, M.S. (2009) The effect of substrate stiffness on adult neural stem cell behavior. Biomaterials, 30, 6867-6878.
91. Cho, Y., Shi, R. and Borgens, R.B. (2010) Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury. J. Exp. Biol., 213, 1513-1520.
92. Thanou, M.,Verhoef, J.C. and Junginger, H.E. (2001) Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Deliv. Rev., 50(Suppl. 1), S91-S101.
93. Illum, L., Farraj, N.F. and Davis, S.S. (1994) Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res., 11, 1186-1189.
94. Schipper, N.G., Olsson, S., Hoogstraate, J.A. et al. (1997) Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm. Res., 14, 923-929.
95. Lehr, C.M., Bouwstra, J.A., Schacht, E.H. and Junginger, H.E. (1992) In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm., 78, 43-48.
96. He, P., Davis, S.S. and Illum, L. (1998) In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int. J. Pharm., 166, 75-88.
97. Kast, C.E. and Bernkop-Schnürch, A. (2001) Thiolated polymers-thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials, 22, 2345-2352.
98. Leitner, V.M., Walker, G.F. and Bernkop-Schnürch, A. (2003) Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. Eur. J. Pharm. Biopharm., 56, 207-214.
99. Vold, I.M.N., Varum, K.M., Guibal, E. and Smidsrod, O. (2003) Binding of ions to chitosan-selectivity studies. Carbohydr. Res., 54, 471-477.
100. Zeng, L., Qin, C., He, G. et al. (2008) Effect of dietary chitosans on trace iron, copper and zinc in mice. Carbohydr. Polym., 74, 279-282.
101. Wang, W., Qin, C., Ding, Y. et al. (2010) Effect of dietary carboxymethyl chitosans on the levels of iron, zinc and copper in mice. Carbohydr. Polym., 81, 203-206.
102. Varma, A.J., Deshpande, S.V. and Kennedy, J.F. (2004) Metal complexation by chitosan and its derivatives: a review. Carbohydr. Polym., 55, 77-93.
103. Okamoto, Y., Kawakami, K., Miyatake, K. et al. (2002) Analgesic effects of chitin and chitosan. Carbohydr. Polym., 49, 249-252.
104. Ito, M., Ban, A. and Ishihara, M. (2000) Anti-ulcer effects of chitin and chitosan, healthy foods, in rats. Jpn. J. Pharmacol., 82, 218-225.
105. Kang, N., Policova, Z., Bankian, G. et al. (2008) Interaction between chitosan and bovine lung extract surfactants. Biochim. Biophys. Acta, 1778, 291-302.
106. Sosa, M.A., Fazely, F., Koch, J.A. et al. (1991) N-carboxymethylchitosan-N,O-sulfate as an anti-HIV-1 agent. Biochem. Biophys. Res. Commun., 174, 489-496.
107. Artan, M., Karadeniz, F., Karagozlu, M.Z. et al. (2010) Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides. Carbohydr. Res., 345, 656-662.
108. Khambualai, O., Yamauchi, K., Tangtaweewipat, S. and Cheva-Isarakul, B. (2009) Growth performance and intestinal histology in broiler chickens fed with dietary chitosan. Br. Poult. Sci., 50, 592-597.
109. Tang, Z.R., Yin, Y.L., Nyachoti, C.M. et al. (2005) Effect of dietary supplementation of chitosan and galactomannan- oligosaccharide on serum parameters and the insulin-like growth factor-I mRNA expression in earlyweaned piglets. Domest. Anim. Endocrinol., 28, 430-441.
110. Razdan, A., Pettersson, D. and Pettersson, J. (1997) Broiler chicken body weights, feed intakes, plasma lipid and small-intestinal bile acid concentrations in response to feeding of chitosan and pectin. Br. J. Nutr., 78, 283-291.
111. Englehart, M.S., Cho, S.D., Tieu, B.H. et al. (2008) A novel highly porous silica and chitosan-based hemostatic dressing is superior to HemCon and gauze sponges. J. Trauma, 65, 884-890, discussion 890-882.
112. Malmquist, J.P., Clemens, S.C., Oien, H.J. and Wilson, S.L. (2008) Hemostasis of oral surgery wounds with the HemCon Dental Dressing. J. Oral Maxillofac. Surg., 66, 1177-1183.
113. Brown, M.A., Daya, M.R. and Worley, J.A. (2009) Experience with chitosan dressings in a civilian EMS system. J. Emerg. Med., 37, 1-7.
114. Francesko, A. and Tzanov, T. (2011) Chitin, chitosan and derivatives for wound healing and tissue engineering. Adv. Biochem. Eng. Biotechnol., 125, 1-27.
115. Ueno, H., Mori, T. and Fujinaga, T. (2001) Topical formulations and wound healing applications of chitosan. Adv. Drug Deliv. Rev., 52, 105-115.
116. Muzzarelli, R.A.A. (2009) Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohydr. Polym., 76, 167-182.
117. Chen, X.G., Wang, Z., Liu, W.S., and Park, H.J. (2002) The effect of carboxymethyl-chitosan on proliferation and collagen secretion of normal and keloid skin fibroblasts. Biomaterials, 23, 4609-4614.
118. Minagawa, T., Okamura, Y., Shigemasa, Y. et al. (2007) Effects of molecular weight and deacetylation degree of chitin/chitosan on wound healing. Carbohydr. Polym., 67, 640-644.
119. Shields, K.M., Smock, N., McQueen, C.E., and Bryant, P.J. (2003) Chitosan for weight loss and cholesterol management. Am. J. Health. Syst. Pharm., 60, 1310-1312, 1315-1316.
120. Kanauchi, O., Deuchi, K., Imasato, Y. et al. (1995) Mechanism for the inhibition of fat digestion by chitosan and for the synergistic effect of ascorbate. Biosci. Biotechnol. Biochem., 59, 786-790.
121. Han, L.K., Kimura, Y. and Okuda, H. (1999) Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet. Int. J. Obes. Relat. Metab. Disord., 23, 174-179.
122. Guerciolini, R., Radu-Radulescu, L., Boldrin, M. et al. (2001) Comparative evaluation of fecal fat excretion induced by orlistat and chitosan. Obes. Res., 9, 364-367.
123. Gades, M.D. and Stern, J.S. (2005) Chitosan supplementation and fat absorption in men and women. J. Am. Diet. Assoc., 105, 72-77.
124. Jull, A.B., Ni Mhurchu, C., Bennett, D.A. et al. (2008) Chitosan for overweight or obesity. Cochrane Database Syst. Rev., CD003892.
125. Micromedex® 2.0, Thomson Healthcare. Available from URL: http://www.thomsonhc.com (accessed January 20, 2011).
126. Ylitalo, R., Lehtinen, S., Wuolijoki, E. et al. (2002) Cholesterol-lowering properties and safety of chitosan. Arzneimittelforschung., 52, 1-7.
127. Nauss, J.L., Thompson, J.L. and Nagyvary, J. (1983) The binding of micellar lipids to chitosan. Lipids, 18, 714-719.
128. Gallaher, C.M., Munion, J., Hesslink, R. Jr. et al. (2000) Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J. Nutr., 130, 2753-2759.
129. Ormrod, D.J., Holmes, C.C. and Miller, T.E. (1998) Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis, 138, 329-334.
130. Murata,Y.,Kojima, N. and Kawashima, S. (2003) Functions of a chitosan-orotic acid salt in the gastrointestinal tract. Biol. Pharm. Bull., 26, 687-690.
131. Hossain, S., Rahman, A., Kabir, Y. et al. (2007) Effects of shrimp (Macrobracium rosenbergii)-derived chitosan on plasma lipid profile and liver lipid peroxide levels in normo- and hypercholesterolaemic rats. Clin. Exp. Pharmacol. Physiol., 34, 170-176.
132. Zhang, J., Liu, J., Li, L. and Xia,W. (2008) Dietary chitosan improves hypercholesterolemia in rats fed high-fat diets. Nutr. Res., 28, 383-390.
133. Neyrinck, A.M., Bindels, L.B., De Backer, F. et al. (2009) Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. Int. Immunopharmacol., 9, 767-773.
134. Maezaki, Y., Tsuji, K., Nakagawa, Y. et al. (1993) Hypocholesterolemic effect of chitosan in adult males. Biosci. Biotechnol. Biochem., 57, 1439-1444.
135. Ausar, S.F., Morcillo, M., Leon, A.E. et al. (2003) Improvement of HDL- and LDL-cholesterol levels in diabetic subjects by feeding bread containing chitosan. J. Med. Food, 6, 397-399.
136. Gades, M.D. and Stern, J.S. (2003) Chitosan supplementation and fecal fat excretion in men. Obes. Res., 11, 683-688.
137. Bokura, H. and Kobayashi, S. (2003) Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial. Eur. J. Clin. Nutr., 57, 721-725.
138. Jaffer, S. and Sampalis, J.S. (2007) Efficacy and safety of chitosan HEP-40 in the management of hypercholesterolemia: a randomized, multicenter, placebo-controlled trial. Altern. Med. Rev., 12, 265-273.
139. Lehtimaki, T., Metso, S., Ylitalo, R. et al. (2005) Microcrystalline chitosan is ineffective to decrease plasma lipids in both apolipoprotein E epsilon 4 carriers and non-carriers: a long-term placebo-controlled trial in hypercholesterolaemic volunteers. Basic Clin. Pharmacol. Toxicol., 97, 98-103.
140. Wuolijoki, E., Hirvela, T. and Ylitalo, P. (1999) Decrease in serum LDL cholesterol with microcrystalline chitosan, methods find. Exp. Clin. Pharmacol., 21, 357-361.
141. Hayashi, Y., Ohara, N., Ganno, T. et al. (2007) Chewing chitosan-containing gum effectively inhibits the growth of cariogenic bacteria. Arch. Oral Biol., 52, 290-294.
142. Busscher, H.J., Engels, E., Dijkstra, R.J. and van der Mei, H.C. (2008) Influence of a chitosan on oral bacterial adhesion and growth in vitro. Eur. J. Oral Sci., 116, 493-495.
143. Shibasaki, K., Sano, H., Matsukubo, T. and Takaesu, Y. (1994) pH response of human dental plaque to chewing gum supplemented with low molecular chitosan. Bull. Tokyo Dent. Coll., 35, 61-66.
144. Sano, H., Shibasaki, K., Matsukubo, T. and Takaesu, Y. (2002) Effect of molecular mass and degree of deacetylation of chitosan on adsorption of Streptococcus sobrinus 6715 to saliva treated hydroxyapatite. Bull. Tokyo Dent. Coll., 43, 75-82.
145. Sano, H., Shibasaki, K., Matsukubo,T. andTakaesu,Y. (2001) Effect of rinsing with phosphorylated chitosan on fourday plaque regrowth. Bull. Tokyo Dent. Coll., 42, 251-256.
146. Sano, H., Shibasaki, K., Matsukubo,T. andTakaesu,Y. (2003) Effect of chitosan rinsing on reduction of dental plaque formation. Bull. Tokyo Dent. Coll., 44, 9-16.
147. Pasquantonio, G., Greco, C., Prenna, M. et al. (2008) Antibacterial activity and anti-biofilm effect of chitosan against strains of Streptococcus mutans isolated in dental plaque. Int. J. Immunopathol. Pharmacol., 21, 993-997.
148. Virga, C., Beltramo, D., Landa, C. et al. (2002) A comparative study in vivo of the therapeutic effect of triclosan, hexetidine and chitosan. Acta Odontol. Latinoam., 15, 3-9.
149. Bae, K., Jun, E.J., Lee, S.M. et al. (2006) Effect of water-soluble reduced chitosan on Streptococcus mutans, plaque regrowth and biofilm vitality. Clin. Oral Investig., 10, 102-107.
150. Jing, S.B., Li, L., Ji, D. et al. (1997) Effect of chitosan on renal function in patients with chronic renal failure. J. Pharm. Pharmacol., 49, 721-723.
151. Savica, V., Calo, L.A., Monardo, P. et al. (2009) Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients. J. Am. Soc. Nephrol., 20, 639-644.
152. Yoon, H.J., Moon, M.E., Park, H.S. et al. (2008) Effects of chitosan oligosaccharide (COS) on the glycerol-induced acute renal failure in vitro and in vivo. Food Chem. Toxicol., 46, 710-716.
153. Park, P.J., Je, J.Y. and Kim, S.K. (2003). Angiotensin I converting enzyme (ACE) inhibitory activity of heterochitooligosaccharides prepared from partially different deacetylated chitosans. J. Agric. Food Chem, 51, 4930-4934.
154. Huang, R., Mendis, E. and Kim, S.K. (2005) Improvement ofACE inhibitory activity of chitooligosaccharides (COS) by carboxyl modification. Bioorg. Med. Chem., 13, 3649-3655.
155. Yuan, Z.X., Zhang, Z.R., Zhu, D. et al. (2009) Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan. Mol. Pharm., 6, 305-314.
156. Baxter, J., Shimizu, F., Takiguchi, Y. et al. (2000) Effect of iron(III) chitosan intake on the reduction of serum phosphorus in rats. J. Pharm. Pharmacol., 52, 863-874.
157. Schöninger, L.M., Dall'Oglio, R.C., Sandri, S. et al. (2010) Chitosan iron(III) reduces phosphorus levels in alloxan diabetes-induced rats with signs of renal failure development. Basic Clin. Pharmacol. Toxicol., 106, 467-471.
158. Nagano, N., Yoshimoto, H., Nishitoba, T. et al. (1995) Pharmacological properties of chitosan-coated dialdehyde cellulose (chitosan DAC), a newly developed oral adsorbent (II): effect of chitosan DAC on rats with chronic renal failure induced by adriamycin. Nippon Yakurigaku Zasshi., 106, 123-133.
159. Willcox, M.D. (2007) New strategies to prevent Pseudomonas keratitis. Eye Contact Lens, 33, 401-403.
160. Yang, H.,Wang, R., Gu, Q. and Zhang, X. (2008) Feasibility study of chitosan as intravitreous tamponade material. Graefes Arch. Clin. Exp. Ophthalmol., 246, 1097-1105.
161. Martinez, L.R., Mihu, M.R., Tar, M. et al. (2010) Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model. J. Infect. Dis., 201, 1436-1440.
162. Landeck, L., Sabath, S., John, S.M. et al. (2010) Antibacterial effects of a chitosan-containing spray: results of a pilot study. J. Drugs Dermatol., 9, 1237-1240.
163. Matsumoto, I., Kaneko, M., Oda, M. and Watanabe, G. (2010) Repair of intra-thoracic autonomic nerves using chitosan tubes. Interact. Cardiovasc. Thorac. Surg., 10, 498-501.
164. Saxena, S., Ray, A.R., Kapil, A. et al. (2011) Development of a new polypropylene-based suture: plasma grafting, surface treatment, characterization, and biocompatibility studies. Macromol. Biosci., 11, 373-382.
165. Berthod, F., Saintigny, G., Chretien, F. et al. (1994) Optimization of thickness, pore size and mechanical properties of a biomaterial designed for deep burn coverage. Clin. Mater., 15, 259-265.
166. Akincibay, H., Şenel, S. and Ay, Z.Y. (2007) Application of chitosan gel in the treatment of chronic periodontitis. J. Biomed. Mater. Res. Part B Appl. Biomater., 80, 290-296.
167. Boynueĝri, D.,Özcan, G., Şenel, S. et al. (2009) Clinical and radiographic evaluations of chitosan gel in periodontal intraosseous defects: a pilot study. J. Biomed. Mater. Res. Part B Appl. Biomater., 90, 461-466.
168. Kim, I.Y., Seo, S.J., Moon, H.S. et al. (2008) Chitosan and its derivatives for tissue engineering applications. Biotechnol. Adv., 26, 1-21.
169. Şenel, S. and McClure, S.J. (2004) Potential applications of chitosan in veterinary medicine. Adv. Drug Deliv. Rev., 56, 1467-1480.
170. Tayel, A.A., Moussa, S., Opwis, K. et al. (2010) Inhibition of microbial pathogens by fungal chitosan. Int. J. Biol. Macromol., 47, 10-14.
171. Lee, D.S., Jeong, S.Y., Kim, Y.M. et al. (2009) Antibacterial activity of aminoderivatized chitosans against methicillin-resistant Staphylococcus aureus (MRSA). Bioorg. Med. Chem., 17, 7108-7112.
172. Tapia, C.P., Soto, D.M.,Vergara, L.G. et al. (2009) Efecto antifúngico de quitosán de alto peso molecular en cepas de Candida sp aisladas de muestras clínicas. Rev. Chilena Infectol., 26, 515-519.